Glitazones are associated with reduced risk of Parkinson’s disease

Patients who take the antidiabetes drugs rosiglitazone or pioglitazone have a lower risk of developing Parkinson’s disease than patients taking other drugs for diabetes, a study published in PLoS Medicine indicates.1

Researchers from the London School of Hygiene and Tropical Medicine used electronic health records from the UK Clinical Practice Research Datalink to match …